Sammy Bell, Ph.D.
Adjunct Professor
Sr. Director, External Alternative CMC, Boehringer Ingelheim
Education
Ph.D., Chemistry/Pharmacology, University of Rhode Island, 2017
M.S., Chemistry, University of Rhode Island, 2007
B.S., Chemistry, University of Connecticut, 2002
Professional Experience
- Boehringer Ingelheim Animal Health (Merial), Duluth, Georgia (Aug 2016 - Present)
- Alcon Laboratories (Novartis), Johns Creek, Georgia (Nov 2012 - Aug 2016)
- Pfizer Global Research and Development, Groton Connecticut (2002 - 2012)
Expertise
- Process chemistry experience from R&D through late stage manufacturing
- Pharmaceutical Scientist with expertise from pre-formulation to late stage formulation development (Ph I/II/III) of parenteral and solid oral dosage forms
- Discovery Chemistry/Research Formulations/Oral Controlled Release/Product Enhancement
- Drug Delivery and Drug Product Development /Manufacture